Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216469 · ClinicalTrials.gov registry record
A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
A clinical trial of Amyloidosis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07216469: Recruiting study of Amyloidosis, sponsored by Mayo Clinic.
NCT07216469 is a study of Amyloidosis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 1,128-participant average among 28 other Amyloidosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216469, a study of Amyloidosis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance elastography (MRE) in patients with cardiac amyloidosis.
Primary Outcome
Magnetic Resonance Elastography exam completion will be determined by signal to noise (SNR) ratio
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Elastography (MRE)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-10-14 |
| Est. Completion | 2027-11 |
What NCT07216469 shows while recruiting
NCT07216469 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,128-participant average among 28 other Amyloidosis trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Amyloidosis appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Elastography (MRE) is the first listed.
NCT07216469 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07216469 about?
NCT07216469 is a clinical study titled "A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography". This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance elastography (MRE) in patients with cardiac amyloidosis.
What is the current status of trial NCT07216469?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-10-14. Estimated completion is 2027-11.
What conditions does trial NCT07216469 study?
This clinical trial studies the following conditions: Amyloidosis.
What interventions are being tested in trial NCT07216469?
The interventions under investigation include: Magnetic Resonance Elastography (MRE) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07216469?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216469 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyloidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07216469's enrollment target sits among peer trials
20 26th of 28 higher than 1 of 28 other Amyloidosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyloidosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
RECRUITING · Phase 2
-
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
RECRUITING
-
Dietary Reporting in the Amyloidoses
RECRUITING · NA
-
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
RECRUITING · Phase 1
-
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
RECRUITING · Phase 2
-
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI